Guna Rajagopal, PhD

Vice President, Global Head, Computational Sciences, Discovery Sciences at Janssen
Pharmaceutical Companies of Johnson and Johnson
Guna is currently the Global Head of Computational Sciences within Discovery Sciences at Janssen R&D. His team is mandated to provide “big data analytics”, high performance computing and genetics/genomics expertise to address and support the evolving need of researchers to identify and validate safe and effective large and small molecule drugs. He is a member of the Discovery Sciences Board, Chair of the R&D Informatics Committee and the J&J Real World Evidence (RWE) Senior Leadership team. Before joining Janssen, Guna was at the Rutgers Cancer Institute of New Jersey (CINJ), a NCI-designated Comprehensive Cancer Center, as Executive Director (Bioinformatics) and an Adjunct Professor of Radiation Oncology at the Robert Wood Johnson Medical School. In addition to providing Bioinformatics support to researchers in Rutgers and Princeton, with funding from the state of New Jersey and the Robert Wood Johnson Foundation, his team deployed inter-operable EMR’s that increases operational efficiency and improved treatment outcomes. The data collected was used to catalyze the Personalized Medicine Initiative at CINJ. He was a member of the Simons Center for Systems Biology at the Institute for Advanced Study, Princeton working with Arnie Levine to develop systems-level approaches to unravel the complex biology of ageing and the genetics of complex diseases such as cancer and autism. Prior to joining CINJ, he was the founding Executive Director of the ASTAR Bioinformatics Institute (BII) at the BIOPOLIS, Singapore. He led the team that developed and deployed state-of-the-art cyber-infrastructure, bioinformatics and high performance computing capabilities to support public and Industry-led research institutes co-located at the BIOPOLIS. He initiated a postgraduate program in Bioinformatics with the National University of Singapore, many of whose graduates have now received PhD’s from world-class universities. Prior to his appointment in Singapore, he spent twelve years at the University of Cambridge, United Kingdom. He was an Assistant Director of Research at the Cavendish Laboratory, where he conducted research and supervised PhD students and postdocs in theoretical and computational physics funded by grants from the UK, EU and Hitachi. He was also a Fellow and Director of Studies in Physics at Jesus College, Cambridge. Guna received his PhD in theoretical physics from the Georgia Institute of Technology and his undergraduate and MSc (in Particle Physics) from the University of Malaya. He is a member of various professional scientific organizations and has sat on research funding bodies in the US, UK, Ireland, Holland, Japan, Malaysia, Singapore, and European Union. He is a visiting professor with the University of Malaya Cancer Research Institute and was a scientific consultant to Unilever, Johnson & Johnson, Novartis AG and Daiichi-Sankyo. He was recently appointed to the Scientific Advisory Board of IMEC, Belgium (to advice on digital technologies in healthcare delivery) and to the Panel of Experts to the European Commission (to advice on the Digital Agenda for Europe Horizon 2020 Flagship Initiative). He can be contacted via email at His profile in LinkedIn ( provides additional information.
None yet.